Initial clinical trial of the retinoid receptor pan agonist 9-cis retinoic acid

Clinical Cancer Research

Volumn 2, Issue 3, 1996, Pages 471-475

  Miller, Vincent A ^a   Rigas, James R ^a   Benedetti, Fabio M ^a   Verret, Amy L ^a   Tong, William P ^b   Kris, Mark G ^a   Gill, George M ^c   Loewen, Gordon R ^c   Truglia, Joseph A ^c   Ulm, Edgar H ^c   Warrell Jr , Raymond P ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

^c LIGAND PHARMACEUTICALS INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALITRETINOIN; RETINOIC ACID RECEPTOR; RETINOIC ACID RECEPTOR AGONIST; UNCLASSIFIED DRUG;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG BLOOD LEVEL; DYSPNEA; FEMALE; FLUSHING; HEADACHE; HUMAN; HYPERCALCEMIA; HYPERTRIGLYCERIDEMIA; MALE; MYALGIA; ORAL DRUG ADMINISTRATION; PHASE 1 CLINICAL TRIAL; PRIORITY JOURNAL; SIDE EFFECT;

ADULT; AGED; ANTINEOPLASTIC AGENTS; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; RECEPTORS, RETINOIC ACID; RETINOID X RECEPTORS; TRANSCRIPTION FACTORS; TRETINOIN;

EID: 9044235574     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Chytil, F. Retinoic acid: Biochemistry, pharmacology, toxicology, and therapeutic use. Pharmacol. Rev., 36: 93S-100S, 1984.
2. Lippman, S., Batsakis, J., Toth, B. B., Weber, R. S , Lee, J. J., Martin, J. W., Hays, G. L., Goepfert, H., and Hong, W. K. Comparison of low-dose isotretinoin with beta carotene to prevent oral carcinogenesis. N. Engl. J Med., 328: 15-20, 1993.
3. Lippman, S. M., Parkinson, D. R., Itri, L. M., Weber, R. S., Schantz, S. P., Ota, D. M., Schusterman, M. A., Krakoff, I. H., Gutterman, J. U., and Hong, W. K. 13-cis-retinoic acid and interferon α-2a: effective combination therapy for advanced squamous cell carcinoma of the skin. J. Natl. Cancer Inst., 84: 235-241, 1992.
4. Lippman, S. M., Kavanagh, J. J., Paredes-Espinoza, M., Delgadillo-Madrueno, F., Paredes-Casillas, P., Hong, W. K., Holdener, E., and Krakoff, I. H. 13-cis-retinoic acid plus interferon α-2a: highly active systemic therapy for squamous cell carcinoma of the cervix. J. Natl. Cancer Inst., 84: 241-245, 1992.
5. Warrell, R. P., Jr., de The, H., Wang, Z. Y., and Degos, L. Acute promyelocytic leukemia. N. Engl. J. Med., 329: 177-189, 1993.
6. Mangelsdorf, D. J. Vitamin A receptors. Nutr. Rev., 52: S32-S44, 1994.
7. Borrow, J., Goddard, A. D., Sheer, D., and Solomon, E. Molecular analysis of acute promyelocytic leukemia breakpoint cluster region on chromosome 17. Science (Washington DC), 249: 1577-1580, 1990.
8. de The, J., Chomienne, C., Lannote, M., Degos, L., and Dejean, A. The t(15;17) translocation of acute promyelocytic leukaemia fuses the retinoic acid receptor a gene to a novel transcribed locus. Nature (Lond.), 347: 558-561, 1990.
9. Mangelsdorf, D. J., Ong, E. S., Dyck, J. A., and Evans, R. M. Nuclear receptor that identifies a novel retinoic acid response pathway. Nature (Lond.), 345: 224-229, 1990.
10. Heyman, R. A., Mangelsdort, D. J., Dyck, J. A., Stein, R. B., Eichele, G., Evans, R. M., and Thaller C. 9-cis retinoic acid is a high affinity ligand for the retinoid X receptor. Cell, 68: 397-406, 1992.
11. Levin, A. A , Sturzenbecker, L. J., Kazmer, S, Bosakowski, T., Huselton, C., Allenby, G., Speck, J., Kratzeisen, C., Rosenberger, M., Lovey, A., and Grippo, J F. 9-cis retinoic acid stereoisomer binds and activates the nuclear receptor RXRα. Nature (Lond.), 355: 359-361, 1992.
12. Sakashita, A., Kizaki, M., Pakkala, S., Schiller, G , Tsuruoka, N., Tomosaki, R., Cameron, J. F., Dawson, M., and Koeffler, H. P. 9-cis-retinoic acid: effects on normal and leukemic hematopoiesis in vitro. Blood, 81: 1009-1016, 1993.
13. Bollag, W , Majewski, S , and Jablonska, S. Cancer combination chemotherapy with retinoids: experimental rationale. Leukemia (Baltimore), 8: 1453, 1994.
14. Creech-Kraft, J., Echoff, C , Kuhnz, W., Lofberg, B., and Nau, H. Automated determination of 13-cis- and all-trans-retinoic acid, their 4-oxo metabolites and retinol in plasma, amniotic fluid and embryo by reversed-phase high-performance liquid chromatography with a precolumn switching technique. J. Liq. Chromat., 11: 2051-2069, 1988.
15. Gibaldi, M., and Perrier, D. Pharmacokinetics, 2nd ed., pp. 480-496. New York: Marcel Dekker, 1982.
16. Miller, V. A., Rigas, J. R., Muindi, J. R. F., Tong, W P , Venkatraman, E., Kris, M. G., and Warrell, R. P., Jr. Modulation of all-trans retinoic acid pharmacokinetics by liarozole. Cancer Chemother. Pharmacol., 34: 522-526, 1994.
17. Rigas, J. R., Francis, P. A, Muindi, J. R. F., Huselton, C., DeGrazia, F., Kris, M. G., Young, C. W., and Warrell, R, P., Jr. Constitutive variability in the pharmacokinetics of the natural retinoid, all-trans retinoic acid, and its modulation by ketoconazole. J. Natl. Cancer Inst., 85: 1921-1926, 1993.
18. Lee, J. S., Newman, R. A., Lippman, S. M., Huber, M. H., Minor, T., Raber, M. N., Krakoff, I. H., and Hong, W. K. Phase I evaluation of all-trans-retinoic acid in adults with solid tumors. J. Clin. Oncol., 11: 959-966, 1993.
19. Bershad, S., Rubinstein, A., Paterniti, J. R., Jr., Le, N. A., Poliak, S., Heller, B., Ginsberg, H N., Fleischmajer, R., and Brown, W. V. Changes in plasma lipids and lipoproteins during isotretinoin therapy for acne. N. Engl. J. Med., 313: 981-985, 1985.
20. Rigas, J. R., Miller, V. A., Levine, D. M., Venkatraman, E. S., Gill, G. M., Truglia, J. A., and Warrell, R. P., Jr. Lipoprotein alterations in patients treated with novel retinoids. Proc. Am. Assoc. Cancer Res., 36: 506, 1995.
21. Keller, H., Dreyer, C., Medin, J., Mahfoudi, A., Ozato, K., and Wahli, W Fatty acids and retinoids control lipid metabolism through activation of peroxisome proliferator-activated receptor-retinoid X receptor heterodimers. Proc. Natl. Acad. Sci. USA, 90: 2160-2164, 1993.
22. Marsden, J. R. Lipid metabolism and retinoid therapy. Pharmacol. Ther., 40: 55-65, 1989.
23. Yu, V. C., Delsert, C., Andersen, B., Holloway, J. M., Devary, O. V., Naar, A. M., Kim, S. Y., Boutin, J. M., Glass, C. K., and Rosenfeld, M. G. RXRβ: A coregulator that enhances binding of retinoic acid, thyroid hormone, and vitamin D receptors to their cognate response elements. Cell, 67: 1251-1266, 1991.
24. Carlberg, C., Bendik, I , Wyss, A., Meier, E., Sturzenbecker, L. J., Grippo, J. F., and Hunziker, W. Two nuclear signaling pathways for vitamin D. Nature (Lond.), 361: 657-660, 1993.
25. Hallenbeck, P. L., Marks, M. S., Lippoldt, R. E., Ozato, K., and Nikodem, V. M. Heterodimerization of thyroid hormone (TH) receptor with H-2RIIBP (RXRβ) enhances DNA binding and TH-dependent transcriptional activation. Proc. Natl. Acad. Sci. USA. 89: 5572-5576, 1992.
26. Zhang, X. K., Hoffman, B., Tran, P. B. V., Graupner, G., and Pfahl, M. Retinoid X receptor is an auxiliary protein for thyroid hormone and retinoic acid receptors. Nature (Lond.), 355: 441-446, 1992.
27. Lee, I. J., Driggers, P. H., Medin, J. A., Nikodem, V. M., and Ozato, K. Recombinant thyroid hormone receptor and retinoid X receptor stimulate ligand-dependent transcription in vitro. Proc. Natl. Acad. Sci. USA, 91: 1647-1651, 1994.
28. Brent, G. A. The molecular basis of thyroid hormone action. N. Engl. J. Med, 331: 847-853, 1994.
29. Muindi, J., Frankel, S., Miller, W., Jakubowski, A., Scheinberg, D. A., Young, C. W , Dmitrovsky, E., and Warrell, R. P., Jr. Continuous treatment with all-trans retinoic acid causes a progressive reduction in plasma drug concentrations: implications for relapse and retinoid "resistance" in patients with acute promyelocytic leukemia. Blood, 79: 299-303, 1992.
30. Adamson, P. C., Murphy, R. F., Godwin, K. A., Ulm, E. H., and Balis, F. M. Pharmacokinetics of 9-cis-retinoic acid in the rhesus monkey. Cancer Res., 55: 482-485, 1995.
31. Achkar, C. C., Bentel, J M., Boylan, J. F., Scher, H. I., Gudas, L. J., and Miller, W. J. Differences in the pharmacokinetic properties of orally administered all-trans-retinoic acid and 9-cis-retinoic acid in the plasma of nude mice. Drug Metab. Dispos., 22: 451-458, 1994.
32. Sass, J. O., Forster, A , Bock, K. W., and Nau, H. Glucuronidation and isomerization of all-trans- and 13- cis-retinoic acid by liver microsomes of phenobarbital or 3-methylcholanthrene-treated rats. Biochem. Pharmacol., 47: 485-492, 1994.
33. Miller, W. H., Jr., Jakubowski, A , Tong, W. P., Miller, V. A., Rigas, J. R., Benedetti, F., Gill, G. M., Truglia, J. A., Ulm, E., Shirley, M., and Warrell, R. P., Jr. 9-cis retinoic acid induces complete remission but does not reverse clinically required retinoid resistance in acute promyelocytic leukemia. Blood, 85: 3021-3027, 1995.
34. Lotan, R., Dawson, M. I., Zou, C. C., Jong, L., Lotan, D., and Zou, C. P. Enhanced efficacy of combinations of retinoic acid- and retinoid X receptor-selective retinoids and α-interferon in inhibition of cervical carcinoma cell proliferation. Cancer Res., 55: 232-236, 1995.